Petros Pharmaceuticals Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 5,112 | 5,822 | 5,992 | 7,811 | 9,560 |
| Cost of Goods | 1,213 | 1,631 | 2,289 | 1,600 | 4,047 |
| Gross Profit | 3,899 | 4,191 | 3,703 | 6,212 | 5,513 |
| Operating Expenses | 21,792 | 18,440 | 23,908 | 24,859 | 22,842 |
| Operating Income | -17,680 | -13,617 | -19,916 | -18,048 | -17,282 |
| Interest Expense | 561 | 536 | 596 | 369 | 3,051 |
| Other Income | 3,922 | 5,990 | 474 | 9,430 | -1,680 |
| Pre-tax Income | -14,319 | -8,163 | -20,038 | -8,987 | -22,013 |
| Income Tax | N/A | N/A | N/A | N/A | -1,427 |
| Net Income Continuous | -14,319 | -8,163 | -20,038 | -8,987 | -20,586 |
| Net Income | $-14,319 | $-8,163 | $-20,038 | $-8,987 | $-20,586 |
| EPS Basic Total Ops | -83.50 | -158.75 | -242.00 | -206.25 | -962.50 |
| EPS Basic Continuous Ops | -44.60 | -93.79 | -242.00 | -206.31 | -963.58 |
| EPS Diluted Total Ops | -83.50 | -158.75 | -242.00 | -206.25 | -962.50 |
| EPS Diluted Continuous Ops | -44.60 | -93.79 | -242.00 | -206.31 | -963.58 |
| EPS Diluted Before Non-Recurring Items | -92.50 | -158.75 | N/A | -425.00 | N/A |
| EBITDA(a) | $-11,769 | $-10,202 | $-6,740 | $-11,158 | $-10,468 |